Immunological veterinary medicinal products, including vaccines, are authorised for rabbits.
| Name | Description | Marketing Authorisation Holder | License Number | License Date | Animal | Further Information |
|---|---|---|---|---|---|---|
|
Eravac |
Rabbit Haemorrhagic Disease (RHD) |
Laboratorios Hipra S.A., Spanien |
EU/2/16/199-/001-002 | 26.09.2016 | Kaninchen | |
FATROVAX RHD |
Rabbit Haemorrhagic Disease (RHD) |
FATRO S.p.A., Italien |
EU/2/21/275 | 16.08.2021 | Kaninchen | |
|
Filavac VHD K C+V |
Rabbit Haemorrhagic Disease (RHD) |
FILAVIE, Roussay, Frankreich |
PEI.V.11900.01.1 | 13.03.2017 | Kaninchen | |
Nobivac Myxo-RHD PLUS |
Myxomatose, Rabbit Haemorrhagic Disease (RHD) |
Intervet International B.V., Niederlande |
EU/2/19/244/001-003 | 19.11.2019 | Kaninchen | |
|
RIKA-VACC Duo |
Myxomatose, Hämorrhagische Krankheit (RHD) |
Ecuphar NV, Belgien |
PEI.V.03071.01.1 | 12.06.2008 | Kaninchen | |
|
RIKA-VACC Myxo sc |
Myxomatose |
Ecuphar NV, Belgien |
PEI.V.03157.01.1 | 12.06.2008 | Kaninchen | |
Yurvac RHD |
Rabbit Haemorrhagic Disease (RHD) |
Laboratorios Hipra, S.A., Spanien |
EU/2/23/298 | 11.09.2023 | Kaninchen |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 531 in BAnz AT 17.07.2025 B3.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 17.07.2025
